Free Trial

Sagespring Wealth Partners LLC Takes $606,000 Position in Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background

Sagespring Wealth Partners LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 1,249 shares of the semiconductor company's stock, valued at approximately $606,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kieckhefer Group LLC bought a new stake in shares of Synopsys in the 4th quarter valued at $27,000. Whipplewood Advisors LLC acquired a new stake in Synopsys during the 4th quarter worth about $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Synopsys during the 4th quarter worth about $34,000. Sierra Ocean LLC bought a new position in shares of Synopsys in the 4th quarter worth about $39,000. Finally, Hazlett Burt & Watson Inc. grew its stake in Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Stock Down 0.6 %

NASDAQ SNPS traded down $2.33 during trading hours on Friday, reaching $413.32. 1,002,399 shares of the company were exchanged, compared to its average volume of 1,091,650. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $624.80. The business's 50 day simple moving average is $446.35 and its 200-day simple moving average is $495.11. The stock has a market capitalization of $63.91 billion, a P/E ratio of 28.47, a P/E/G ratio of 3.23 and a beta of 1.23.

Insider Activity at Synopsys

In other news, CEO Sassine Ghazi sold 11,366 shares of Synopsys stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. The trade was a 13.81 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Geus Aart De sold 15,705 shares of the firm's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company's stock, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on SNPS shares. KeyCorp reduced their price objective on shares of Synopsys from $690.00 to $555.00 and set an "overweight" rating for the company in a research report on Tuesday. Bank of America decreased their target price on Synopsys from $630.00 to $560.00 and set a "buy" rating for the company in a research report on Wednesday. Needham & Company LLC reissued a "buy" rating and issued a $650.00 price objective on shares of Synopsys in a research note on Thursday, February 27th. Redburn Atlantic initiated coverage on shares of Synopsys in a research report on Monday, January 13th. They issued a "buy" rating and a $600.00 price target for the company. Finally, Rosenblatt Securities reaffirmed a "buy" rating and issued a $660.00 price objective on shares of Synopsys in a research note on Tuesday, February 25th. One analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $618.31.

Read Our Latest Analysis on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Read More

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines